Evidence map›Paper›PMID 41915823›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Enzymatic Basis for the Oxidative Branch of Aromatic Amino Acid Fermentation Leading to p-cresol Formation.

Li Jiang, Yifeng Wei, Xumei Liu, Dazhi Liu, Zhenyu Liu, Yang Tong, Jinyu Yin, Ankanahalli N Nanjaraj Urs, Meining Xing, Mark A Harrison and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Li JiangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Yifeng WeiSingapore Institute of Food and Biotechnology Innovation, Agency for Science, Technology and Research (A∗STAR), Singapore.
Xumei LiuNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Dazhi LiuNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Zhenyu LiuKey Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Yang TongNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Jinyu YinNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Ankanahalli N Nanjaraj UrsNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0002-1357-6733
Meining XingNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Mark A HarrisonDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Chuyuan ZhangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Sheng YangKey Laboratory of Synthetic Biology, Center For Excellence of Molecular Plant Science, Chinese Academy of Sciences, Shanghai, China.
Yunzi LuoKey Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0002-5860-6350
Ee Lui AngSingapore Institute of Food and Biotechnology Innovation, Agency for Science, Technology and Research (A∗STAR), Singapore.
Huimin ZhaoDepartment of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID https://orcid.org/0000-0002-9069-6739
Yan ZhangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0003-2031-0631

Funding

Agency for Science, Research and Technology of Singapore Visiting Investigator ProgramDistinguished Young Scholar of China Program 32125002National Natural Science Foundation of China 31570060National Natural Science Foundation of China 31870049New Cornerstone Science Foundation NCI202321
6 · The paper itself

Abstract

The phenolic metabolite p-cresol is a byproduct of tyrosine fermentation by certain strictly anaerobic bacteria, including the human gut pathogen Clostridium difficile, with toxic effects on the host and intestinal microbiota. The only enzyme in this biochemical pathway characterized to date is the glycyl radical enzyme p-hydroxyphenylacetate (HPA) decarboxylase (HPAD), which catalyzes the terminal step. Here we report the identification and characterization of enzymes for anaerobic degradation of tyrosine to HPA in the model p-cresol-producing bacterium Clostridium scatologenes. In this pathway, tyrosine is first converted to p-hydroxyphenylpyruvate (HPP), followed by net oxidation to HPA by a trio of enzymes HPP: ferredoxin oxidoreductase (HpdDEFG), phosphate HPA-transferase (HpdJ) and HPA kinase (HpdK). Each step is thermodynamically reversible, and the pathway is coupled to net generation of ATP and reduced ferredoxin. A bioinformatics search reveals that gene clusters containing a similar trio of enzymes are widespread in anaerobic Firmicutes bacteria, suggesting analogous pathways for the degradation of other amino acids. These findings clarify the oxidative pathways by which anaerobic gut bacteria convert aromatic amino acids into a major class of aromatic metabolites including HPA and p-cresol, deepening our understanding of microbiota-host metabolic interactions.

Indexed as

Amino Acids, AromaticCarboxy-LyasesClostridioides difficileCresolsFermentationOxidation-ReductionTyrosine4-cresol4-hydroxyphenylacetate decarboxylaseAmino Acids, AromaticCarboxy-LyasesCresolsTyrosine

Identifiers

PMID41915823
PMCPMC13285125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.